The Arteriovenous Malformations (AVM) treatment market involves medical procedures and devices that are used for the treatment of arteriovenous malformations (AVMs). AVMs are abnormal connections between the arteries and veins that bypass the normal capillary bed. The arteriovenous malformations can occur in the brain, spine, lungs, or other parts of the body.              

                                                                                                                                                      Surgery, endovascular embolization, stereotactic radiotherapy, and other techniques are used for the treatment of Arteriovenous Malformations Market depending on the size and location of the lesion.

The global AVM treatment market is estimated to be valued at US$ 575.8 million in 2030 and is expected to exhibit a CAGR of 6.8% over the forecast period from 2022 to 2030.
Key Takeaways
Key players operating in the Arteriovenous Malformations (AVM) treatment market are Stryker Corporation, Medtronic plc, Johnson & Johnson Services Inc., Terumo Corporation, Penumbra Inc. Major players are engaged in new product development and acquisitions to strengthen their market position. For instance, in 2020, Stryker Corporation acquired Wright Medical, a leading extremities and biologics company to expand its presence in the orthopaedics market.
The demand for AVM treatment procedures and devices is growing due to the rising prevalence of this medical condition globally. According to estimates, there are around 300,000 people in the United States that are currently living with an untreated brain AVM. Increasing awareness regarding AVM risk factors and symptoms is further driving individuals to seek treatment.
Key market players are focused on expanding their geographical presence by strengthening their distribution networks across emerging regions. Growing healthcare expenditures in developing countries, especially in Asia Pacific, is creating new opportunities for international players. Advancements in embolic materials, navigation systems and radiosurgery technology are also supporting the market growth.
Market Drivers
The major driver contributing to the growth of the AVM treatment market is the increasing incidence of arteriovenous malformations globally. Risk factors such as family history, female gender, and head trauma can increase the chances of developing AVMs. According to statistics, the prevalence of brain AVMs ranges between 0.13% to 0.18% globally. Growing geriatric population who are at a higher risk of AVMs is another major demand inducing factor. Improvement in diagnostic techniques is also enabling early detection of AVMs thereby driving the adoption of treatment procedures.
The ongoing geopolitical conflicts and tensions are impacting the growth of the Arteriovenous Malformations Market. With increasing conflicts and sanctions between major economies, cross-border trade and collaborations relating to R&D are taking a hit. This adversely impacts innovation and access to advanced treatment techniques in this market.
Countries in the Middle East and Africa have seen tremendous political instability and security issues over the past few years due to conflicts and terrorism. This has distracted governments from prioritizing investments in advanced healthcare infrastructures and technologies. It has also made it difficult for global companies offering AVMs treatment solutions to expand into these high growth regions.
However, there are some geographies which still offer opportunities. The Asia Pacific region, despite escalating geopolitical tensions between some nations, continues to be the fastest growing market for AVMs treatment. This can be attributed to rising healthcare expenditures, growing medical tourism, and increasing focus of governments on Non Communicable Diseases. Countries like India, China, Japan and South Korea are concentrating efforts on building world-class healthcare facilities and attracting global innovations.
North America has been the largest market for AVMs treatment historically due to high per capita healthcare spending and rapid adoption of advanced treatment technologies. The United States in particular has a well-established reimbursement structure and presence of leading product innovators. However, Europe has emerged as another major regional hub. This can be attributed to collective efforts of the European Union towards research, streamlining of regulations and ensuring high quality, affordable healthcare for all.
The growing geopolitical uncertainties make it very important for companies in this sector to diversify and de-risk their business models, supply chains and distribution networks. They need to focus on building local manufacturing and service capabilities in different geographies to insulate themselves from trade wars or sanctions targeted at certain nations. Collaborating with local healthcare providers and partnering with regional medtech players can also help gain better understanding for customized solutions and stronger footholds in diverse markets.

Get more insights on : Arteriovenous Malformations Market

About Author:

Ravina Pandya, Content Writer, has a strong foothold in the market research industry. She specializes in writing well-researched articles from different industries, including food and beverages, information and technology, healthcare, chemical and materials, etc. (https://www.linkedin.com/in/ravina-pandya-1a3984191)